Deal Making

Featured on Deal Making

Aquisition
Deal-Making
Novartis sells France CGT biz to SeqensNovartis sells France CGT biz to Seqens

byShreeyashi Ojha
Dec 19, 2023
|
2 Min Read
Cancer
Deal-Making
Merck taps into C4T’s degrader-antibody conjugate techMerck taps into C4T’s degrader-antibody conjugate tech
byShreeyashi Ojha
Dec 18, 2023
2 Min Read
UCL
Deal-Making
ViroCell inks CAR-T manufacturing pact with UCLViroCell inks CAR-T manufacturing pact with UCL
byMillie Nelson
Dec 18, 2023
1 Min Read
thumbnail logo in a gray background |
Deal-Making
Ins and Outs, High level changes at CDMOsIns and Outs, High level changes at CDMOs
byShreeyashi Ojha
Dec 13, 2023
3 Min Read
thumbnail logo in a gray background |
Deal-Making
Oxford Biomedica acquires ABL EuropeOxford Biomedica acquires ABL Europe
byShreeyashi Ojha
Dec 7, 2023
1 Min Read
Roche weighs in on obesity drug market with $2.7bn Carmot buy
Deal-Making
Roche weighs in on obesity drug market with $2.7bn Carmot buyRoche weighs in on obesity drug market with $2.7bn Carmot buy
byMillie Nelson
Dec 4, 2023
3 Min Read

More from Deal Making

Oblique
Deal-Making
Oblique taps into AAX’s seqitope tech
Oblique taps into AAX’s seqitope tech
Dec 1, 2023
|
2 Min Read
byShreeyashi Ojha
AbbVie going big on ADCs through $10bn ImmunoGen buy
Deal-Making
AbbVie going big on ADCs through $10bn ImmunoGen buy
AbbVie going big on ADCs through $10bn ImmunoGen buy
Dec 1, 2023
|
2 Min Read
byDan Stanton
Vertex/CRISPR selects RoslinCT as CDMO for Casgevy
Deal-Making
Vertex/CRISPR selects RoslinCT as CDMO for Casgevy
Vertex/CRISPR selects RoslinCT as CDMO for Casgevy
Nov 29, 2023
|
2 Min Read
byMillie Nelson
Hovione adds function materials through ExtremoChem acquisition
Deal-Making
Hovione adds function materials through ExtremoChem acquisition
Hovione adds function materials through ExtremoChem acquisition
Nov 28, 2023
|
1 Min Read
byMillie Nelson
Dyadic, Afreximaxbank partner to bolster affordable vaccine production
Deal-Making
Dyadic, Afreximaxbank partner to bolster affordable vaccine production
Dyadic, Afreximaxbank partner to bolster affordable vaccine production
Nov 28, 2023
|
2 Min Read
byShreeyashi Ojha
Syncona bids $28m to progress Gaucher disease gene therapy
Deal-Making
Syncona bids $28m to progress Gaucher disease gene therapy
Syncona bids $28m to progress Gaucher disease gene therapy
Nov 28, 2023
|
2 Min Read
byShreeyashi Ojha
Ajinomoto jumps into gene therapy CDMO space through $620m Forge buy
Deal-Making
Ajinomoto jumps into gene therapy CDMO space through $620m Forge buy
Ajinomoto jumps into gene therapy CDMO space through $620m Forge buy
Nov 15, 2023
|
2 Min Read
byShreeyashi Ojha
Legend and Novartis sign $100m CAR-T license agreement
Deal-Making
Legend and Novartis sign $100m CAR-T license agreement
Legend and Novartis sign $100m CAR-T license agreement
Nov 15, 2023
|
2 Min Read
byShreeyashi Ojha
Century and Fujifilm double down on stem cell therapy deal
Deal-Making
Century and Fujifilm double down on stem cell therapy deal
Century and Fujifilm double down on stem cell therapy deal
Nov 14, 2023
|
1 Min Read
byShreeyashi Ojha
Investor Elliott reportedly takes $1bn stake in BioMarin
Deal-Making
Investor Elliott reportedly takes $1bn stake in BioMarin
Investor Elliott reportedly takes $1bn stake in BioMarin
Nov 10, 2023
|
2 Min Read
byMillie Nelson
Landmark Bio to manufacture oncology CAR-T for Galapagos
Deal-Making
Landmark Bio to manufacture oncology CAR-T for Galapagos
Landmark Bio to manufacture oncology CAR-T for Galapagos
Nov 9, 2023
|
2 Min Read
byMillie Nelson
Cabaletta
Deal-Making
Cabaletta to TAP into Cellares' cell shuttle
Cabaletta to TAP into Cellares' cell shuttle
Nov 8, 2023
|
2 Min Read
byShreeyashi Ojha
BioNTech buys LNP startup and seeks further M&A opps
Deal-Making
BioNTech buys LNP startup and seeks further M&A opps
BioNTech buys LNP startup and seeks further M&A opps
Nov 8, 2023
|
2 Min Read
byMillie Nelson
c/o BioCina
Deal-Making
BioCina partners with GPN Vaccines against Streptococcus pneumoniae
BioCina partners with GPN Vaccines against Streptococcus pneumoniae
Nov 6, 2023
|
2 Min Read
byShreeyashi Ojha
triveni bio
Deal-Making
Triveni Bio raises $92m to take on I&I disorders
Triveni Bio raises $92m to take on I&I disorders
Nov 6, 2023
|
1 Min Read
byShreeyashi Ojha
Novartis bids on bluebird’s next FDA PRV for $103m
Deal-Making
Novartis bids on bluebird’s next FDA PRV for $103m
Novartis bids on bluebird’s next FDA PRV for $103m
Nov 3, 2023
|
2 Min Read
byShreeyashi Ojha
AstraZeneca forks out $245m to bolster gene therapy pipeline
Deal-Making
AstraZeneca forks out $245m to bolster gene therapy pipeline
AstraZeneca forks out $245m to bolster gene therapy pipeline
Nov 3, 2023
|
2 Min Read
byShreeyashi Ojha
Eli Lilly bags Beam’s licensing rights in Verve agreement for $250m
Deal-Making
Eli Lilly bags Beam’s licensing rights in Verve agreement for $250m
Eli Lilly bags Beam’s licensing rights in Verve agreement for $250m
Nov 3, 2023
|
2 Min Read
byMillie Nelson
Medigene selects AGC to manufacture cancer cell therapy
Deal-Making
Medigene selects AGC to manufacture cancer cell therapy
Medigene selects AGC to manufacture cancer cell therapy
Nov 1, 2023
|
2 Min Read
byShreeyashi Ojha
Rampart bags $85m in Series A financing round for non-viral gene therapies
Deal-Making
Rampart bags $85m in Series A financing round for non-viral gene therapies
Rampart bags $85m in Series A financing round for non-viral gene therapies
Oct 31, 2023
|
2 Min Read
byMillie Nelson
Merck KGaA bolsters oncology pipeline with Hengrui partnership
Deal-Making
Merck KGaA bolsters oncology pipeline with Hengrui partnership
Merck KGaA bolsters oncology pipeline with Hengrui partnership
Oct 31, 2023
|
2 Min Read
byMillie Nelson
Samsung Biologics strikes manufacturing and development deal with Kurma
Deal-Making
Samsung Biologics strikes manufacturing and development deal with Kurma
Samsung Biologics strikes manufacturing and development deal with Kurma
Oct 30, 2023
|
2 Min Read
byMillie Nelson
GSK forks out $85m for Hansoh gynecology cancer ADC
Deal-Making
GSK forks out $85m for Hansoh gynecology cancer ADC
GSK forks out $85m for Hansoh gynecology cancer ADC
Oct 30, 2023
|
2 Min Read
byRichard Daverman
Forge Biologics joins CIRM to manufacture AAV gene therapies
Deal-Making
Forge Biologics joins CIRM to manufacture AAV gene therapies
Forge Biologics joins CIRM to manufacture AAV gene therapies
Oct 25, 2023
|
2 Min Read
byShreeyashi Ojha
French gov awards Astraveus $11m to advance CGT platform
Deal-Making
French gov awards Astraveus $11m to advance CGT platform
French gov awards Astraveus $11m to advance CGT platform
Oct 24, 2023
|
3 Min Read
byMillie Nelson
Merck amplifies ADC focus in $5.5bn Daiichi Sankyo deal
Deal-Making
Merck amplifies ADC focus in $5.5bn Daiichi Sankyo deal
Merck amplifies ADC focus in $5.5bn Daiichi Sankyo deal
Oct 23, 2023
|
2 Min Read
byDan Stanton
GenomeFrontier taps BioCina to make DNA for CAR-T programs
Deal-Making
GenomeFrontier taps BioCina to make DNA for CAR-T programs
GenomeFrontier taps BioCina to make DNA for CAR-T programs
Oct 23, 2023
|
2 Min Read
byShreeyashi Ojha
KKR acquires minority stake in life sciences firm Catalio
Deal-Making
KKR acquires minority stake in life sciences firm Catalio
KKR acquires minority stake in life sciences firm Catalio
Oct 20, 2023
|
3 Min Read
byMillie Nelson
Emergex inks deal with VIC to bolster Saudi Arabia healthcare accessibility
Deal-Making
Emergex inks deal with VIC to bolster Saudi Arabia healthcare accessibility
Emergex inks deal with VIC to bolster Saudi Arabia healthcare accessibility
Oct 18, 2023
|
3 Min Read
byMillie Nelson
SpliceBio deal adds extra ‘spark’ to Roche CGT ambitions
Deal-Making
SpliceBio deal adds extra ‘spark’ to Roche CGT ambitions
SpliceBio deal adds extra ‘spark’ to Roche CGT ambitions
Oct 18, 2023
|
2 Min Read
byDan Stanton

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: What if Your Supply Chain for Single-Use Equipment Was Robust?
Register Now: What if Your Supply Chain for Single-Use Equipment Was Robust?
Ask the Expert webcasts
ATE Webcasts
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Tosoh AEX Method
Sponsored Content
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis

Oct 14, 2024

LumaCyte LFC™
Sponsored Content
Label-Free Monitoring of T-Cell Activation Using Laser Force Cytology™
Label-Free Monitoring of T-Cell Activation Using Laser Force Cytology™

Oct 14, 2024

ValGenesis CSV to CSA
Sponsored Content
The Shift from CSV to CSA
The Shift from CSV to CSA

Oct 14, 2024